- Donanemab significantly slowed clinical progression of Alzheimer’s Disease at 76 weeks in those with low/medium tau https://jamanetwork.com/journals/jama/fullarticle/2807533 3 comments science
Linking pages
- Alzheimer’s Biomarker Test May Detect Disease Years before Tau Tangles Appear https://www.genengnews.com/topics/translational-medicine/alzheimers-biomarker-test-may-detect-disease-years-before-tau-tangles-appear/ 3 comments
- Biomarker Test Can Detect Alzheimer's Pathology Earlier, Pitt Study Shows | School of Medicine | University of Pittsburgh https://www.medschool.pitt.edu/news/biomarker-test-can-detect-alzheimers-pathology-earlier-pitt-study-shows 3 comments
- Lilly Alzheimer’s drug gets unanimous backing of FDA panel | BioPharma Dive https://www.biopharmadive.com/news/donanemab-alzheimers-fda-advisers-panel-vote-lilly/718505/ 1 comment